NSRX Nasus Pharma Ltd
NYSE · SEC CIK 2029039 · EDGAR
- Bought, last 12 months
- $61.8K 3 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 3 since 2026-04-01, latest 2026-06-22 07:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Teleman Dan Benjamin | CEO, Dir | $61.8K | — |
Transactions 3
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 07:12 | 2026-06-17 | NSRX | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $3.10 | +6,550 | 163.5K | +4% | +$20.3K | |
| 2026-04-22 21:44 | 2026-04-22 | NSRX | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $3.76 | +2,900 | 157.0K | +2% | +$10.9K | |
| 2026-04-01 07:31 | 2026-03-31 | NSRX | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $2.04 | +15.0K | 21.2K | +240% | +$30.6K |
Purchase Sale Sale after option exercise All abbreviations